NYSE:XPOF • US98422X1019
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XPONENTIAL FITNESS INC-A (XPOF).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Guggenheim | Maintains | Buy -> Buy |
| 2026-02-27 | Baird | Maintains | Neutral -> Neutral |
| 2025-11-21 | Stifel | Maintains | Hold -> Hold |
| 2025-11-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-17 | UBS | Initiate | Neutral |
| 2025-08-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-05-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-05-09 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-03-14 | Lake Street | Maintains | Buy -> Buy |
| 2025-03-14 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2025-03-14 | Stifel | Downgrade | Buy -> Hold |
| 2025-03-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-23 | Northland Capital Markets | Initiate | Market Perform |
| 2025-01-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-11 | Stifel | Maintains | Buy -> Buy |
| 2024-11-08 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-08-05 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-08-02 | Roth MKM | Maintains | Buy -> Buy |
| 2024-08-02 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-08-02 | Baird | Maintains | Neutral -> Neutral |
| 2024-08-02 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2024-07-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-06-18 | Guggenheim | Maintains | Buy -> Buy |
| 2024-05-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-05-03 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 317.937M 29.77% | 320.346M 0.76% | 314.879M -1.71% | 281.54M -10.59% | 297.21M 5.57% | 306.71M 3.20% | |
| EBITDA YoY % growth | 63.95M 76.56% | 86.561M 35.36% | 57.645M -33.41% | 110.74M 92.11% | 120.02M 8.38% | 133.52M 11.25% | |
| EBIT YoY % growth | 47.067M 125.20% | 68.848M 46.28% | 45.618M -33.74% | 85.058M 86.46% | 109.1M 28.27% | 113.93M 4.43% | |
| Operating Margin | 14.80% | 21.49% | 14.49% | 30.21% | 36.71% | 37.15% | |
| EPS YoY % growth | 0.24 119.05% | -0.10 -141.67% | -0.51 -410.00% | 0.72 240.44% | 1.06 48.58% | 2.15 102.24% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.14 168.85% | 0.18 -29.38% | 0.26 -24.63% | 0.26 128.18% | 0.31 122.22% | 0.48 161.11% | 0.49 93.03% | 0.53 106.82% | 0.71 133.33% | 0.72 51.06% |
| Revenue Q2Q % growth | 66.975M -12.89% | 68.507M -10.11% | 78.75M -0.09% | 80.225M -3.30% | 88.582M 32.26% | 90.188M 31.65% | 92.121M 16.98% | 94.977M 18.39% | 101.18M 14.22% | 102.92M 14.12% |
| EBITDA Q2Q % growth | 26.345M 311.70% | 28.096M -14.17% | 31.896M -11.34% | 32.019M 588.88% | 31.36M 19.04% | 38.816M 38.15% | 38.219M 19.82% | 40.31M 25.89% | N/A | N/A |
| EBIT Q2Q % growth | 14.316M 315.80% | 17.177M -35.92% | 22.861M -13.30% | 23.238M 414.92% | 22.083M 54.25% | 30.039M 74.88% | 29.585M 29.41% | 31.809M 36.88% | N/A | N/A |
All data in USD
16 analysts have analysed XPOF and the average price target is 11.12 USD. This implies a price increase of 84.38% is expected in the next year compared to the current price of 6.03.
XPONENTIAL FITNESS INC-A (XPOF) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of XPONENTIAL FITNESS INC-A (XPOF) is 0.14 USD and the consensus revenue estimate is 66.97M USD.
The consensus rating for XPONENTIAL FITNESS INC-A (XPOF) is 77.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.